NCT03161587View on ClinicalTrials.gov

Patient Characteristics and Treatment Modalities in COPD Patients in China

CompletedOBSERVATIONAL
Enrollment

848

Participants

Timeline

Start Date

May 31, 2017

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2018

Conditions
Pulmonary Disease, Chronic Obstructive
Trial Locations (8)

100032

GSK Investigational Site, Beijing

200025

GSK Investigational Site, Shanghai

361004

GSK Investigational Site, Xiamen

410011

GSK Investigational Site, Changsha

510120

GSK Investigational Site, Guangzhou

610041

GSK Investigational Site, Chengdu

010017

GSK Investigational Site, Hohhot

Unknown

GSK Investigational Site, Zhengzhou

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY